XML 27 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2015   77,952        
Beginning balance at Dec. 31, 2015 $ 1,146,268 $ 882 $ 446,672 $ 953,516 $ (28,389) $ (226,413)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 92,349     92,349    
Other comprehensive (loss) income (12,521)       (12,521)  
Common dividends declared ($0.36, $0.39 and $0.45) (29,191)     (29,191)    
Acquisition, net of issuance costs (in shares)   3,042        
Acquisition, net of issuance costs 54,896 $ 31 54,865      
Common stock issued (in shares)   13        
Common stock issued 227   227      
Restricted stock activity (in shares)   326        
Restricted stock activity (2,673)   (10,685)     8,012
Treasury stock issued to benefit plans (in shares)   (8)        
Treasury stock issued to benefit plans (154)   (21)     (133)
Share-based compensation expense 7,879   7,879      
Ending balance (in shares) at Dec. 31, 2016   81,325        
Ending balance at Dec. 31, 2016 1,257,080 $ 913 498,937 1,016,674 (40,910) (218,534)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 98,387     98,387    
Other comprehensive (loss) income 7,874       7,874  
Common dividends declared ($0.36, $0.39 and $0.45) (40,071)     (40,071)    
Acquisition, net of issuance costs (in shares)   21,078        
Acquisition, net of issuance costs 534,090 $ 210 533,322     558
Common stock issued (in shares)   9        
Common stock issued 240   240      
Restricted stock activity (in shares)   317        
Restricted stock activity (3,659)   (11,855)     8,196
Treasury stock issued to benefit plans (in shares)   (12)        
Treasury stock issued to benefit plans (290)   3     (293)
Share-based compensation expense $ 11,223   11,223      
Ending balance (in shares) at Dec. 31, 2017 102,717 102,717        
Ending balance at Dec. 31, 2017 $ 1,864,874 $ 1,123 1,031,870 1,074,990 (33,036) (210,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Adjustments to apply recent accounting pronouncements [1] 0     6,689 (6,689)  
Net income 157,870     157,870    
Other comprehensive (loss) income (12,787)       (12,787)  
Common dividends declared ($0.36, $0.39 and $0.45) (46,782)     (46,782)    
Acquisition, net of issuance costs (in shares)   3,311        
Acquisition, net of issuance costs 83,303 $ 33 83,270      
Common stock issued (in shares)   39        
Common stock issued 961 $ 1 293     667
Restricted stock activity (in shares)   311        
Restricted stock activity (4,421)   (12,983)     8,562
Treasury stock issued to benefit plans (in shares)   (3)        
Treasury stock issued to benefit plans (82)   68     (150)
Share-based compensation expense $ 12,062   12,062      
Ending balance (in shares) at Dec. 31, 2018 106,375 106,375        
Ending balance at Dec. 31, 2018 $ 2,054,998 $ 1,157 $ 1,114,580 $ 1,192,767 (52,512) $ (200,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Adjustments to apply recent accounting pronouncements [1]         $ (6,689)  
[1] As a result of accounting guidance adopted in 2018, certain reclassifications were made from accumulated other comprehensive loss to retained earnings as of January 1, 2018. For further discussion of this guidance, see Note 2. "Recent Accounting Pronouncements."